Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica

Future Microbiology

Volumn 4, Issue 1, 2009, Pages 105-116

  Lejeune, Manigandan ^a   Rybicka, Joanna M ^a   Chadee, Kris ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Amoebiasis; Cell biology; Entamoeba histolytica; Epidemiology; Immunology; Immunosuppression; Pathogenesis; Vaccine

Indexed keywords

GAL LECTIN VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 72; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 5; LIPOPHOSPHOGLYCAN; MUCIN 2; NITRIC OXIDE; PROSTAGLANDIN E2; PROTOZOAL VACCINE; REACTIVE OXYGEN METABOLITE; RECOMBINANAT SERINE RICH ENTAMOEBA HISTOLYTICA PROTEIN; SERINE PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AMEBIASIS; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; ENTAMOEBA HISTOLYTICA; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER AMEBIASIS; MICROBIAL COLONIZATION; MIXED INFECTION; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; VACCINATION; ANIMAL; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PARASITOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY;

ANIMALS; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; MICE;

ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; PROTOZOA;

EID: 61749092694     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.4.1.105     Document Type: Review

References (111)

1. Huston CD: Parasite and host contributions to the pathogenesis of amebic colitis. Trends Parasitol. 20, 23-26 (2004).
2. Loftus B, Anderson I, Davies R et al.: The genome of the protist parasite Entamoeba histolytica. Nature 433 (7028), 865-868 (2005).
3. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J: PCR detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in stool samples from Sydney, Australia. J. Clin. Microbiol. 45(3), 1035-1037 (2007).
4. Ramos F, Morán P, González E et al.: High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community. Am. J. Trop. Med. Hyg. 73(1), 87-91 (2005).
5. Ramos F, Morán P, González E et al.: Entamoeba histolytica and Entamoeba dispar: prevalance infection in a rural Mexican community. Exp. Parasitol. 110, 327-330 (2005).
6. Haque R, Mondal D, Duggal P et al.: Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect. Immun. 74(2), 904-909 (2006).
7. Mondal D, Petri WA Jr, Sack RB, Kirkpatrick BD, Haque R: Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Trans. R. Soc. Trop. Med. Hyg. 100(11), 1032-1038 (2006).
8. Rivera W, Santos S, Kanbara H: Prevalance and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in Philipines. Parasitol. Res. 98, 106-110 (2006).
9. Haghighi A, Kobayashi S, Takeuchi T, Thammapalerd N, Nozaki T: Geographic diversity among genotypes of Entamoeba histolytica field isolates. J. Clin. Microbiol. 41(8), 3748-3756 (2003).
10. Haghighi A, Kobayashi S, Takeuchi T, Masuda G, Nozaki T: Remarkable genetic polymorphism among Entamoeba histolytica isolates from limited geographic area. J. Clin. Microbiol. 40(11), 4081-4090 (2002).
11. Ayeh-Kumi P, Ali I, Lockhart L, Gilchrist C, Petri W, Hague R: Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Exp. Parasitol. 99, 80-88 (2001).
12. Blessmann J, Ali IK, Nu PA et al.: Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers. J. Clin. Microbiol. 41(10), 4745-4750 (2003).
13. Haque R, Duggal P, Ali IM et al.: Innate and acquired resistance to amebiasis in Bangladeshi children. J. Infect. Dis. 186(4), 547-552 (2002).
14. Duggal P, Haque R, Roy S et al.: Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J. Infect. Dis. 189(3), 520-526 (2004).
15. Moncada D, Keller K, Chadee K: Entamoeba histolytica-secreted products degrade colonic mucin oligosaccharides. Infect. Immun. 73(6), 3790-3793 (2005).
16. Lidell ME, Moncada DM, Chadee K, Hansson GC: Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc. Natl Acad. Sci. USA 103(24), 9298-9303 (2006).
17. Tavares P, Rigothier MC, Khun H, Roux P, Huerre M, Guillén N: Roles of cell adhesion and cytoskeleton activity in Entamoeba histolytica pathogenesis: a delicate balance. Infect. Immun. 73(3), 1771-1778 (2005).
18. Lauwaet T, Oliveira MJ, De Bruyne G: Entamoeba histolytica trophozoites transfer lipophosphopeptidoglycans to enteric cell layers. Int. J. Parasitol. 34(5), 549-556 (2004).
19. Macfarlane RC, Singh U: Identification of an Entamoeba histolytica serine, threonine and isoleucine rich protein with roles in adhesion and cytotoxicity. Eukaryot. Cell. 6(11), 2139-2146 (2007).
20. Lauwaet T, Oliveira MJ, Callewaert B et al.: Proteolysis of enteric cell villin by Entamoeba histolytica cysteine proteinases. J. Biol. Chem. 278(25), 22650-22656 (2003).
21. Leroy A, De Bruyne G, Mareel M, Nokkaew C, Bailey G, Nelis H: Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture. Infect. Immun. 63(11), 4253-4260 (1995).
22. Leroy A, Lauwaet T, De Bruyne G, Cornelissen M, Mareel M: Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers. FASEB J. 14(9), 1139-1146 (2000).
23. Sharma M, Vohra H, Bhasin D: Enhanced pro-inflammatory chemokine/ cytokine response triggered by pathogenic Entamoeba histolytica: basis of invasive disease. Parasitology 131(6), 783-796 (2005).
24. Que X, Kim SH, Sajid M: A surface amebic cysteine proteinase inactivates interleukin-18. Infect. Immun. 71(3), 1274-1280 (2003).
25. Choi MH, Sajed D, Poole L: An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Mol. Biochem. Parasitol. 143(1), 80-89 (2005).
26. Davis PH, Zhang X, Guo J, Townsend RR, Stanley SL Jr: Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence. Mol. Microbiol. 61(6), 1523-1532 (2006).
27. Riahi Y, Siman-Tov R, Ankri S: Molecular cloning, expression and characterization of a serine proteinase inhibitor gene from Entamoeba histolytica. Mol. Biochem. Parasitol. 133(2), 153-162 (2004).
28. Sim S, Park SJ, Yong TS, Im KI, Shin MH: Involvement of β(2)-integrin in ROS-mediated neutrophil apoptosis induced by Entamoeba histolytica. Microbes Infect. 9(11), 1368-1375 (2007).
29. Elnekave K, Siman-Tov R, Ankri S: Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. Parasite Immunol. 25(11-12), 597-608 (2003).
30. Huston CD, Boettner DR, Miller-Sims V, Petri WA Jr: Apoptotic killing and phagocytosis of host cells by the parasite Entamoeba histolytica. Infect. Immun. 71(2), 964-972 (2003).
31. Flores RD, Rosales C, Rosales JL, Talamás RP: Entamoeba histolytica: a β1 integrin-like fibronectin receptor assembles a signaling complex similar to those of mammalian cells. Exp. Parasitol. 103(1-2), 8-15 (2003).
32. Zhang X, Zhang Z, Alexander D, Bracha R, Mirelman D, Stanley SL Jr: Expression of amoebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infect. Immun. 72(2), 678-683 (2004).
33. Tillack M, Nowak N, Lotter H et al.: Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica. Mol. Biochem. Parasitol. 149(1), 58-64 (2006).
34. Santi-Rocca J, Weber C, Guigon G, Sismeiro O, Coppée JY, Guillén N: The lysine- and glutamic acid-rich protein KERP1 plays a role in Entamoeba histolytica liver abscess pathogenesis. Cell Microbiol. 10(1), 202-217 (2008).
35. Bredeston LM, Caffaro CE, Samuelson J, Hirschberg CB: Golgi and endoplasmic reticulum functions take place in different subcellular compartments of Entamoeba histolytica. J. Biol. Chem. 280(37), 32168-32176 (2005).
36. Salgado M, Villagómez-Castro JC, Rocha RR: Entamoeba histolytica: biochemical and molecular insights into the activities within microsomal fractions. Exp. Parasitol. 110(4), 363-373 (2005).
37. Chan KW, Slotboom DJ, Cox S et al.: A novel ADP/ATP transporter in the mitosome of the microaerophilic human parasite Entamoeba histolytica. Curr. Biol. 15(8), 737-742 (2005).
38. Marion S, Laurent C, Guillén N: Signalization and cytoskeleton activity through myosin IB during the early steps of phagocytosis in Entamoeba histolytica: a proteomic approach. Cell Microbiol. 7(10), 1504-1518 (2005).
39. Saito NY, Yasuda T, Nakada TK, Leippe M, Nozaki T: Rab5-associated vacuoles play a unique role in phagocytosis of the enteric protozoan parasite Entamoeba histolytica. J. Biol. Chem. 279(47), 49497-49507 (2004).
40. Saito NY, Mitra BN, Nakada TK, Sato D, Nozaki T: Two Rab7 isotypes, EhRab7A and EhRab7B, play, distinct roles in biogenesis of lysosomes and phagosomes in the enteric protozoan parasite Entamoeba histolytica. Cell Microbiol. 9(7), 1796-1808 (2007).
41. Ocádiz R, Orozco E, Carrillo E et al.: EhCP112 is an Entamoeba histolytica secreted cysteine protease that may be involved in the parasite-virulence. Cell Microbiol. 7(2), 221-232 (2005).
42. Laughlin RC, McGugan GC, Powell RR, Welter BH, Temesvari LA: Involvement of raft-like plasma membrane domains of Entamoeba histolytica in pinocytosis and adhesion. Infect. Immun. 72(9), 5349-5357 (2004).
43. Wender N, Villalobo E, Mirelman D: EhLim A, a novel LIM protein, localizes to the plasma membrane in Entamoeba histolytica. Eukaryot. Cell. 6(9), 1646-1655 (2007).
44. Sahoo N, Labruyère E, Bhattacharya S, Sen P, Guillén N, Bhattacharya A: Calcium binding protein 1 of the protozoan parasite Entamoeba histolytica interacts with actin and is involved in cytoskeleton dynamics. J. Cell. Sci. 117(16), 3625-3634 (2004).
45. Winkelmann J, Leippe M, Bruhn H: A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity. Mol. Biochem, Parasitol. 147(1), 85-94 (2006).
46. Ramakrishnan G, Gilchrist CA, Musa H et al.: Histone acetyltransferases and deacetyiase in Entamoeba histolytica. Mol. Biochem. Parasitol. 138(2), 205-216 (2004).
47. Hackney JA, Ehrenkaufer GM, Singh U: Identification of putative transcriptional regulatory networks in Entamoeba histolytica using Bayesian inference. Nucleic Acids Res. 35(7), 2141-2152 (2007).
48. Gilchrist CA, Holm CF, Hughes MA, Schaenman JM, Mann BJ, Petri WA Jr: Identification and characterization of an Entamoeba histolytica upstream regulatory element 3 sequence-specific DNA-binding protein containing EF-hand motifs. J. Biol. Chem. 276(15), 11838-11843 (2001).
49. McGugan GC Jr, Joshi MB, Dwyer DM: Identification and biochemical characterization of unique secretory nucleases of the human enteric pathogen, Entamoeba histolytica. J. Biol. Chem. 282(43), 31789-31802 (2007).
50. Kammanadiminti SJ, Chadee K: Suppression of NF-κB activation by Entamoeba histolytica in intestinal epithelial cells is mediated by heat shock protein 27. J. Biol. Chem. 281(36), 26112-26120 (2006).
51. Belkaid Y: Regulatory T cells and infection, a dangerous necessity. Nat. Rev. Immunol. 7(11), 875-888 (2007).
52. Ghosh PK, Castellanos-Barba C, Ortiz-Ortiz L: Intestinal amebiasis: cyclic suppression of the immune response. Parasitol Res. 81(6), 475-480 (1995).
53. Soboslay PT, Hamm DM, Pfafflin F, Fendt J, Banla M, Schulz-Key H: Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment. Microbes Infect 8(1), 238-247 (2006).
54. Bekker-Mendez VC, Perez-Castillo VL, Rico-Rosillo MG et al.: Downregulation of selected cytokines in amebiasis. Arch. Med. Res. 37(4), 556-558 (2006).
55. Ventura-Juarez J, Jarillo-Luna RA, Fuentes-Aguilar E et al.: Human amoebic hepatic abscess: in situ interactions between trophozoites, macrophages, neutrophils and T cells. Parasite Immunol. 25(10), 503-511 (2003).
56. + T cells. J. Immunol. 169(8), 4496-4503 (2002).
57. Guo X, Stroupt SE, Houpt ER: Persistance of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFNγ. Mucosal Immunol. 1(2), 139-146 (2008).
58. Stenson WF, Zhang Z, Riehl T, Stanley SL Jr: Amebic infection in the human colon induces cyclooxygenase-2. Infect. Immun. 69(5), 3382-3388 (2001).
59. Dey I, Keller K, Belley A, Chadee K: Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc. Natl Acad. Sci. USA 100(23), 13561-13566 (2003)
60. Dey I, Lejeune M, Chadee K: Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br. J. Pharmacol. 149(6), 611-623 (2006).
61. Morelli AE, Thomson AW: Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7(8), 610-621 (2007).
62. Kretschmer R, Collado ML, Pacheco MG et al.: Inhibition of human monocyte locomotion by products of axenically grown E. histolytica. Parasite Immunol. 7(5), 527-543 (1985).
63. Kretschmer RR, Rico G, Gimenez JA: A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol. Biochem. Parasitol. 112(2), 201-209 (2001).
64. Kietschmer RR, Castro EM, Pacheco G, Rico G, Diaz-Guerra O, Arellano J: The role of mannose in the receptor of the monocyte locomotion inhibitory factor produced by Entamoeba histolytica. Parasitol. Res. 77(5), 374-378 (1991).
65. Gimenez-Scherer JA, Pacheco-Cano MG, Cruz DL, Hernandez-Jauregui P, Merchant MT, Kretschmer RR: Ultrastructural changes associated with the inhibition of monocyte chemotaxis caused by products of axenically grown Entamoeba histolytica. Lab Invest. 57(1), 45-51 (1987).
66. Rico G, Arellano J, Kretschmer RR: The human monocyte locomotion-inhibitory factor produced by Entamoeba histolytica does not inhibit the locomotion of human eosinophils. Parasitol. Res. 84(6), 522-523 (1998).
67. Rico G, Leandro E, Rojas S, Gimenez J, Kretschmer R: The effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon nitric oxide production by human leukocytes. Arch. Med. Res. 31(Suppl. 4), S90-S91 (2000).
68. Rico G, Leandro E, Rojas S, Gimenez JA, Kretschmer RR: The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol. Res. 90(4), 264-267 (2003).
69. Gimenez-Scherer JA, Arenas E, Diaz L, Rico G, Fernandez J, Kretschmer R: Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica on the expression of cell adhesion molecules (CAMs) in the skin of guinea pigs. Arch. Med. Res. 31(Suppl. 4), S92-S93 (2000).
70. Utrera-Barillas D, Velazquez JR, Enciso A et al.: An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines. Parasite Immunol. 25(10), 475-482 (2003).
71. Lotter H, Jacobs T, Gaworski I, Tannich E: Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect. Immun. 74(1), 118-124 (2006).
72. Denis M, Chadee K: Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect. Immun. 57(6), 1750-1756 (1989).
73. Lin JY, Chadee K: Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J. Immunol. 148(12), 3999-4005 (1992).
74. Hamano S, Becker S, Asgharpour A et al.: Gender and genetic control of resistance to intestinal amebiasis in inbred mice. Genes Immun. 9(5), 452-461 (2008).
75. Hung CC, Deng HY, Hsiao WH et al.: Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch. Intern. Med. 165(4), 409-415 (2005).
76. Ko NY, Lee HC, Chang JL et al.: Prevalence of humah immunodeficiency virus and sexually transmitted infections and risky sexual behaviors among men visiting gay bathhouses in Taiwan. Sex. Transm. Dis. 33(8), 467-473 (2006).
77. Brown M, Reed S, Levy JA, Busch M, McKerrow JH: Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells. AIDS 5(1), 93-96 (1991).
78. Moran P, Ramos F, Ramiro M et al.: Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis. Am. J. Trop. Med. Hyg. 73(2), 296-300 (2005).
79. Hung CC, Ji DD, Sun HY et al.: Increased risk for Entamoeba histolytica infection and invasive amoebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl. Trop. Dis. 2(2), e175 (2008).
80. Chen Y, Zhang Y, Yang B et al.: Seroprevalence of Entamoeba histolytica infection in HIV-infected patients in China. Am. J. Trop. Med. Hyg. 77(5), 825-828 (2007).
81. + T cells by dendritic cells in HIV-infected persons with amebic liver abscess. J. Acquir. Immune. Defic. Syndr. 44(1), 6-13 (2007).
82. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr: Amebiasis. N. Engl. J. Med. 348(16), 1565-1573 (2003).
83. Stanley SL: Vaccines for amoebiasis: barriers and opportunities. Parasitology 133(Suppl.), S81-S86 (2006).
84. Stanley SL, Blanchard JL, Johnson N et al.: Immunogenicity of recombinant serine rich Entamoeba histolytica protein (SREPH) in African green monkeys. Vaccine 13, 947-951, (1995).
85. Abd Alla MD, White GL, Roger TB et al.: Adherence inhibitory intestinal immunoglobulin A antibody response in baboons elicited by use of a synthetic intranasal lectin-based ameobiasis subunit vaccine. Infect. Immun. 75(8), 3812-3822 (2007).
86. Abd Alla MD, Jackson TF, Soong GC, Mazanee M, Ravdin JI: Identification of the Entamoeba histolytica galactose-inhibitable lectin epitopes recognized by Human immunoglobulin A antibodies following cure of amebic liver abscess. Infect. Immun. 72(7), 3974-3980 (2004).
87. Haque R, Ali IM, Sack B et al.: Amebiasis. and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J. Infect. Dis. 183, 1787-1793 (2001).
88. Houpt E, Barroso L, Lockhart L et al.: Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine 22(5-6), 611-617 (2004).
89. Ivory C, Chadee K: Intranasal immunization with Gal inhabitable lectin plus an adjuvant CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge. Infect. Immun. 75(10), 4917-4922 (2007).
90. Golding B, Scott DE: Vaccine strategies: targeting T helper cell responses. Ann. NY Acad. Sci. 754(1), 126-137 (1995).
91. Campbell D, Chadee K: Interleukin (IL)-2, IL-4, and tumor necrosis factor-α responses during Entamoeba histolytica liver abscess development in gerbils. J. Infect. Dis. 175(5), 1176-1183 (1997).
92. Salata RA, Pearson RD, Ravdin JI: Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J. Clin. Invest. 76(2), 491-499 (1985).
93. Seguin R, Mann BJ, Keller K, Chadee K: Identification of the galacrose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-α production by macrophages. Proc. Natl Acad. Sci. USA 92(26), 12175-12179 (1995).
94. Seguin R, Keller K, Chadee K: Entamoeba histolytica stimulates the unstable transcription of c-fos and tumour necrosis factor-α mRNA by protein kinase C signal transduction in macrophages. Immunology 86(1), 49-57 (1995).
95. Seguin R, Mann BJ, Keller K, Chadee K: The tumor necrosis factor α-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates γ interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect. Immun. 65(7), 2522-2527 (1997).
96. Ramos E, Olivos-Garcia A, Nequiz M et al.: Entamoeba histolytica: apoptosis induced in vitro by nitric oxide species. Exp. Parasitol. 116(3), 257-265 (2007).
97. Romani L, Puocetti P, Bistoni F: Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10(4), 611-636 (1997).
98. Campbell D, Mann BJ, Chadee K: A subunit vaccine candidate region of the Entamoeba histolytica galactose-adherence lectin promotes interleukin-12 gene transcription and protein production in human macrophages. Eur. J. Immunol. 30(2), 423-430 (2000).
99. Ivory CP, Chadee K: Activation of dendritic cells by the Gal - lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo. Eur. J. Immunol 37(2), 385-394 (2007).
100. Ivory CP, Keller K, Chadee K: CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils. Infect. Immun. 74(1), 528-536 (2006).
101. Askew D, Chu RS, Krieg AM, Harding CV: CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J. Immunol. 165(12), 6889-6895 (2000).
102. Behboudi S, Chao D, Klenerman P, Austyn J: The effects of DNA containing CpG motif on dendritic cells. Immunology 99(3), 361-366 (2000).
103. Decker T, Schneller F, Kronschnabl M et al.: Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp. Hematol. 28(5), 558-568 (2000).
104. Krieg AM: Immune effects and mechanisms of action of CpG motifs. Vaccine 19(6), 618-622 (2000).
105. Ivory CP, Prystajecky M, Jobin C, Chadee K: TLR-9 dependent macrophage activation by Entamoeba histolytica DNA. Infect. Immun. 76(1), 289-297 (2008).
106. Bujanover S, Katz U, Bracha R, Mirelman D: A virulence attenuated amoebapore-less mutant of Entamoeba histolytica and its interaction with host cells. Int. J. Parasitol. 33(14), 1655-1663 (2003).
107. Lopez CM, Orozco E, Sanchez T et al.: The EhADH112 recombinant polypeptide inhibits cell destruction and liver abscess formation by Entamoeba histolytica trophozoites. Cell. Microbiol. 6(4), 367-376 (2004).
108. Gimenez-Scherer JA, Cardenas G, Lopez-Osuna M et al.: Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by Entamoeba hisolytica protects gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver. Parasite Immunol. 26, 343-349 (2004).
109. Lotter H, Rüssmann H, Heesemann J, Tannich E: Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis. Int. J. Med. Microbiol. 298(1-2), 79-86 (2008).
110. Lotter H, Khajawa F, Stanley SL Jr, Tannich E: Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin. Infect. Immun. 68(8), 4416-4421 (2000).
111. Baxt LA, Baker RP, Singh U, Urban S: An Entamoeba histolytica, rhomboid protease with atypical specificity cleaves a surface lectin involved in phagocytosis and immune evasion. Genes Dev. 22, 1636-1646 (2008).